NVO
Novo Nordisk A/SHealthcare · $169.9B market cap
Verdict
Share price
$37.32
close of Oct 3, 2026
Fair value
$64.11
Sticker Price
Payback Price
$25.65
buy price
NVO is Undervalued: at $37.32 it trades 42% below its fair value of $64.11. Its buy price (Payback Price) is $25.65, 31% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
4 of 5 clear the 10% bar. What are the Big Five?
Follow NVO
Get notified when it reaches its buy price of $25.65. Free.
Create a free accountSuperinvestors
4 of the investors we track hold NVO. In Q2 2026, 1 added, 1 trimmed and 1 sold out. Who we track
About Novo Nordisk A/S
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business…
Drug Manufacturers - General
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works